Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Related Citations for PubMed (Select 21838846)

1.

Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.

Meszaros ZS, Dimmock JA, Ploutz-Snyder RJ, Abdul-Malak Y, Leontieva L, Canfield K, Batki SL.

Am J Addict. 2011 Sep-Oct;20(5):462-7. doi: 10.1111/j.1521-0391.2011.00150.x. Epub 2011 Jul 18.

2.

Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.

Scheller-Gilkey G, Woolwine BJ, Cooper I, Gay O, Moynes KA, Miller AH.

Am J Drug Alcohol Abuse. 2003 Aug;29(3):553-66.

PMID:
14510040
3.

Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.

Stauffer VL, Song G, Kinon BJ, Ascher-Svanum H, Chen L, Feldman PD, Conley RR.

Schizophr Res. 2012 Feb;134(2-3):195-201. doi: 10.1016/j.schres.2011.09.028. Epub 2011 Oct 21.

PMID:
22019076
4.

Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.

Zhang XY, Chen da C, Tan YL, Xiu MH, Cui J, Hui L, De Yang F, Kosten TR.

Psychopharmacology (Berl). 2014 Jan;231(1):305-14. doi: 10.1007/s00213-013-3239-x. Epub 2013 Aug 21.

PMID:
23963531
5.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
6.

Item response analysis of the Positive and Negative Syndrome Scale.

Santor DA, Ascher-Svanum H, Lindenmayer JP, Obenchain RL.

BMC Psychiatry. 2007 Nov 15;7:66.

7.

Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.

Bobes J, Arango C, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group.

J Clin Psychiatry. 2010 Mar;71(3):280-6. doi: 10.4088/JCP.08m04250yel. Epub 2009 Nov 3. Erratum in: J Clin Psychiatry. 2011 Jul;72(7):1017.

PMID:
19895779
8.
9.

[Factors related to suicide attempts in a Tunisian sample of patients with schizophrenia].

Bouhlel S, M'solly M, Benhawala S, Jones Y, El-Hechmi Z.

Encephale. 2013 Feb;39(1):6-12. doi: 10.1016/j.encep.2012.06.003. Epub 2012 Sep 25. French.

PMID:
23095582
10.

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.

Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K.

Schizophr Res. 2004 Apr 1;67(2-3):157-66.

PMID:
14984874
11.

Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.

Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.

J Psychiatr Res. 2006 Oct;40(7):669-76. Epub 2006 Jun 9.

PMID:
16762371
12.

Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.

Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ.

J Clin Psychiatry. 1999 Nov;60(11):747-51.

PMID:
10584762
13.

Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.

Batki SL, Leontieva L, Dimmock JA, Ploutz-Snyder R.

Schizophr Res. 2008 Oct;105(1-3):201-7. doi: 10.1016/j.schres.2008.06.020. Epub 2008 Aug 13.

14.

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.

J Clin Psychiatry. 2002 Oct;63(10):931-5.

PMID:
12416603
15.

Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Kotov R, Guey LT, Bromet EJ, Schwartz JE.

Schizophr Bull. 2010 Jan;36(1):173-81. doi: 10.1093/schbul/sbn066. Epub 2008 Jun 17.

16.

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.

Conley RR, Mahmoud R.

Am J Psychiatry. 2001 May;158(5):765-74. Erratum in: Am J Psychiatry 2001 Oct;158(10):1759.

PMID:
11329400
17.

The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.

Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S.

J Clin Psychiatry. 2009 Jan;70(1):25-35. Epub 2008 Dec 2.

PMID:
19192472
18.

Predictors of switching antipsychotic medications in the treatment of schizophrenia.

Nyhuis AW, Faries DE, Ascher-Svanum H, Stauffer VL, Kinon BJ.

BMC Psychiatry. 2010 Sep 28;10:75. doi: 10.1186/1471-244X-10-75.

19.

Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.

Zhang XY, Chen da C, Xiu MH, Yang FD, Haile CN, Kosten TA, Kosten TR.

J Clin Psychiatry. 2012 Jul;73(7):1025-33. doi: 10.4088/JCP.11m07422.

PMID:
22901352
20.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk